NeuroPace, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
NPCE Nasdaq 3841 www.neuropace.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for NeuroPace, Inc.

How The NeuroPace (NPCE) Investment Story Is Shifting Without A New Analyst Price Target - Jun 2nd, 2026 4:07 pm
NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting - May 29th, 2026 6:05 am
NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care - May 29th, 2026 6:00 am
Is NPCE Stock a Buy in 2026 After DIXI Exit and Margin Lift? - May 27th, 2026 8:58 am
NPCE Explains How NeuroPace's RNS System Makes Money - May 27th, 2026 8:45 am
NeuroPace NPCE and the Next Wave of AI-Driven Epilepsy Care - May 27th, 2026 8:34 am
NeuroPace (NPCE) Q1 2026 Earnings Transcript - May 14th, 2026 1:23 pm
NeuroPace, Inc. (NASDAQ:NPCE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year - May 14th, 2026 12:54 pm
NeuroPace, Inc. Q1 2026 Earnings Call Summary - May 13th, 2026 6:30 am
NeuroPace Inc (NPCE) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ... - May 12th, 2026 11:02 pm
NeuroPace Q1 Earnings Call Highlights - May 12th, 2026 7:09 pm
NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates - May 12th, 2026 3:40 pm
NeuroPace Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Guidance - May 12th, 2026 2:05 pm
NeuroPace (NPCE) Moves 6.3% Higher: Will This Strength Last? - May 7th, 2026 7:32 am
NeuroPace to Report First Quarter 2026 Financial Results on May 12, 2026 - Apr 29th, 2026 2:05 pm
NeuroPace Highlights Expanding Clinical Evidence Leadership with Published 3-Year Post-Approval Study (PAS) Results in Neurology and NAUTILUS Presentation at AAN 2026 - Apr 27th, 2026 5:30 am
NeuroPace to Present at the 25th Annual Needham Virtual Healthcare Conference - Apr 10th, 2026 2:05 pm
NeuroPace (NPCE) Up 0.9% Since Last Earnings Report: Can It Continue? - Apr 2nd, 2026 9:30 am
Here's Why You Should Add NeuroPace Stock to Your Portfolio Now - Apr 2nd, 2026 9:22 am
Wall Street Analysts See a 41.29% Upside in NeuroPace (NPCE): Can the Stock Really Move This High? - Apr 2nd, 2026 7:55 am